# Akira Robinson

> Akira Robinson is a biotech and pharmaceutical commercialization leader with roughly two decades of experience turning early-stage science into market-ready medicine. He is a Partner and Chief Experience Officer at the life-sciences consultancy Scimitar Inc. and serves as interim Chief Commercial Officer at Nucleus RadioPharma. He built and scaled the launch practice at EVERSANA to more than 20 consultants, and has stepped into interim CCO and COO seats across the industry. With a Harvard biochemistry degree, a Johns Hopkins biotech master's, and a stint as a Wall Street biotech equity analyst, he blends scientific fluency with commercial operating chops, lately focused on radiopharmaceutical therapies and AI-driven commercialization.

- **Role:** Partner & Chief Experience Officer at Scimitar Inc.
- **Organizations:** Scimitar Inc., Nucleus RadioPharma, EVERSANA, Fusion Community Empowerment, Inc., Baxter
- **Nationality:** American
- **Education:** B.A. in Biochemical Sciences, Harvard University (Harvard College), M.S. in Biotechnology, The Johns Hopkins University, Digital Transformation and AI Playbooks (certificate), Stanford University Graduate School of Business
- **Known for:** Built EVERSANA's launch practice from the ground up, scaling it to more than 20 consultants, Led product launches across multiple therapeutic areas, Served as interim Chief Commercial Officer and Chief Operating Officer for life-sciences organizations

## Career timeline

- **early career** — Began in biopharma at Baxter, working in Hemophilia
- **mid career** — Covered biotechnology companies as an equity research analyst on Wall Street
- **mid career** — Consulting roles across New York, London, and Los Angeles spanning data analytics, competitive intelligence, and strategy
- **recent** — Built and scaled the launch practice at EVERSANA to 20+ consultants focused on launch readiness, strategy, and PMO support
- **recent** — Served in interim Chief Commercial Officer and Chief Operating Officer capacities for life-sciences clients
- **2022** — Joined the board of Fusion Community Empowerment, Inc.
- **2025** — Named Chief Commercial Officer (Ad Interim) at Nucleus RadioPharma (Nov 1, 2025)
- **2026** — Partner & Chief Experience Officer at Scimitar Inc.; completed Stanford GSB AI Playbooks certificate; attended BIO International Convention 2026 in San Diego

## Achievements

- Built EVERSANA's launch practice from the ground up, scaling it to more than 20 consultants
- Led product launches across multiple therapeutic areas
- Served as interim Chief Commercial Officer and Chief Operating Officer for life-sciences organizations
- Appointed interim Chief Commercial Officer at radiopharma CDMO Nucleus RadioPharma
- Published an article on data encryption in medical devices (2015)

## Latest updates

- **2025-11** — Began serving as Chief Commercial Officer (Ad Interim) at Nucleus RadioPharma
- **2026-01** — Completed Stanford GSB Digital Transformation and AI Playbooks certificate
- **2026-06** — Attended the BIO International Convention 2026 in San Diego, speaking on AI-driven drug discovery and commercial strategy

## Links

- Website: https://scimitar.com/team/profile-akira-robinson/
- LinkedIn: https://www.linkedin.com/in/akirajrobinson/
- Twitter/X: https://x.com/scienceakira

---

Profile page: https://yespress.io/akira-robinson
Published by YesPress — https://yespress.io
Last updated: 2026-06-29